Fig. 1.

Flowchart of eligibility of patients considered for inclusion. Eligible indications included: developmental delay, cognitive impairment, autism spectrum disorder, myopathy, rhabdomyolysis, encephalopathy, “rule out metabolic disorder”, or “rule out mitochondrial disorder”. *For analysis purposes, only unique diagnoses (1 per family) were considered. Therefore, n = 8 for analysis.